Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Anal cancer, Secondary cancers
Closed
Phase 2
This trial is looking at adding retifanlimab to chemotherapy to improve treatment for people with anal cancer.
It is for people:
who can’t have surgery to remove the cancer and
whose cancer has come back after previous treatment or it has spread elsewhere in the body
Recruitment start: 11 February 2021
Recruitment end: 31 May 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sheela Rao
Incyte Corporation
Last reviewed: 30 May 2023
CRUK internal database number: 17943
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
